ARCHIVES

Dose Dense Chemotherapy Regimen Improves Survival In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished

November 29, 1996

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011

Siemens To Provide Technology To DxTx For Lung Cancer Detection.

December 14, 2001

Cancer Informatics: NCI Writing Dictionary To Standardize Data Reported In Trials

November 13, 1998

Cancer Centers Win Majority Of Grants In Recent NCI RFAs, Klausner Tells AACI.

October 6, 2000

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

April 11, 2003